Introduction to Semaglutide Raw Material
Semaglutide raw material for sale from our facility consists of a synthetic 31-amino acid peptide that functions as a glucagon-like peptide-1 (GLP-1) receptor agonist. The sequence is engineered with two key modifications: an aminoisobutyric acid substitution at position 8 and a C-18 fatty diacid chain linked to lysine at position 26 via a hydrophilic spacer. These structural features are well documented in the biochemical literature and confer high albumin affinity and resistance to dipeptidyl peptidase-4 (DPP-4) cleavage under experimental conditions. Researchers source this lyophilized powder to investigate incretin receptor biology in a controlled laboratory setting.
This material is manufactured exclusively for laboratory research applications. It is not produced or tested for administration to humans or animals, and no therapeutic endpoint is implied. Each shipment carries clear labeling that reinforces its research-only status. Maintaining a purity level ≥98% as measured by high-performance liquid chromatography ensures that experimental variables introduced by peptide heterogeneity are minimized, supporting reproducibility in receptor binding, signaling, and stability studies.
Chemical Properties and Characterization
The molecular formula of semaglutide is C₁₈₇H₂₉₁N₄₅O₅₉, corresponding to a monoisotopic molecular weight of 4113.58 g/mol. The peptide is supplied as a sterile, lyophilized white to off-white powder that is readily soluble in aqueous buffers commonly used in cell-based or biochemical assays. The lipidated side chain drives reversible binding to serum albumin in vitro, a property that prolongs its half-life in circulation-based experimental models—a feature frequently exploited to study extended receptor engagement.
Identity and purity are confirmed through orthogonal analytical methods:
- HPLC: Reverse-phase chromatograms at 214 nm and 280 nm demonstrate a single predominant peak with ≥98% area integration. The retention time is consistent with the lipophilic character of the acylated peptide.
- Mass spectrometry: Electrospray ionization (ESI) or matrix-assisted laser desorption/ionization (MALDI) spectra exhibit the expected [M+H]⁺ ion clusters. High-resolution instruments measure monoisotopic masses within ±1 Da of the theoretical value.
- Amino acid analysis: Hydrolysis followed by derivatization confirms the expected composition, including the non-standard Aib residue.
For reconstitution, researchers typically use sterile Dulbecco’s phosphate-buffered saline or neutral pH buffers. Gentle agitation is recommended; vortexing should be avoided to prevent aggregation of the lipophilic peptide. Once dissolved, the stock solution should be aliquoted and stored at −20°C or below, as freeze-thaw cycles can compromise structural integrity.
Applications de la recherche
Semaglutide raw material enables a broad spectrum of in vitro and ex vivo investigations centered on GLP-1 receptor pharmacology. Typical applications include:
- Receptor binding kinetics: Radioligand displacement or surface plasmon resonance assays to measure affinity (Kd) and residence time. The lipidated peptide’s interaction with membrane preparations or whole cells expressing recombinant GLP-1R provides data relevant to structure-activity relationship studies.
- Signal transduction profiling: Measurement of cAMP accumulation, calcium mobilization, or β-arrestin recruitment using luciferase complementation or fluorescence-based reporters. These functional assays are routinely performed in CHO-K1 or HEK293 cell lines stably transfected with human, mouse, or rat GLP-1 receptors.
- Peptide stability and degradation: Incubation in plasma, tissue homogenates, or simulated biological fluids under controlled conditions helps map enzymatic cleavage sites and aggregation pathways. Such data inform formulation strategies for lab-scale experiments.
- Preclinical animal studies: Rodent or non-rodent models employed under approved ethical protocols use this peptide to explore metabolic regulation, energy homeostasis, and gut-brain signaling. All such work must comply with institutional animal care guidelines and national regulations; our product is labeled accordingly.
Additionally, the raw material serves as a reference standard for developing analytical methods—such as LC-MS/MS quantification of peptide concentrations in research samples—or as a starting point for producing fluorescent or affinity-tagged probes via custom derivatization.
Quality Control and Specifications
Every production batch undergoes a comprehensive panel of analytical tests, and the results are compiled in a Certificat d'analyse (CoA) that ships with the product. The CoA reports net peptide weight, purity (area‑% by HPLC), molecular mass confirmation, solubility assessment, and storage instructions. Typical specifications:
- Purity (HPLC, 214 nm): ≥98.0%
- Molecular mass (ESI‑MS): Within ±1.0 Da of 4113.58
- Appearance: White lyophilized powder
- Solubility: Clear solution at 1 mg/mL in PBS, pH 7.4, after brief sonication
- Endotoxin: ≤0.1 EU per mg (tested by Limulus amebocyte lysate assay for cell‑culture grade orders)
In addition to the standard HPLC and MS tests, a subset of batches undergoes amino acid analysis to verify the primary structure, and counter-ion determination (usually acetate or trifluoroacetate) to correct for salt content. Stability studies are ongoing; the current recommendation is to store the lyophilized powder at −20°C in a tightly sealed vial with desiccant, protected from light. Under these conditions, the peptide remains stable for at least two years from the date of manufacture. Reconstituted aliquots should be stored at −80°C and used within one week to minimize deamidation and aggregation.
Packaging and Shipping Information
We offer semaglutide raw material in standard vial formats—5 mg, 10 mg, 25 mg, and 100 mg—as well as bulk quantities up to several grams for large-scale research programs. Each vial is sealed under an argon or nitrogen overlay, capped with a bromobutyl rubber stopper, and crimped with an aluminum flip‑off seal to ensure an oxygen‑ and moisture‑free environment. Bulk orders are packaged in sterile polyethylene containers or double‑bagged with desiccant packs.
All consignments are dispatched using validated cold‑chain logistics. Domestic shipments travel with refrigerated gel packs, while international orders are typically shipped on dry ice in expanded polystyrene containers rated for extended hold times. Temperature loggers or indicator strips can be included upon request to verify that the product remained within the specified temperature range during transit. Our shipping practices comply with IATA Dangerous Goods Regulations and the European Agreement concerning the International Carriage of Dangerous Goods by Road (ADR) where applicable. The outer packaging bears clear hazard‑communication labels for research chemicals and contains all necessary customs documentation, including a commercial invoice and a safety data sheet (SDS).
Why Source Semaglutide from Our Company
We operate a vertically integrated peptide manufacturing platform governed by current Good Manufacturing Practice (cGMP) principles. Our synthesis laboratories are equipped with automated solid‑phase synthesizers, preparative HPLC systems, and lyophilizers capable of delivering multi‑gram batches with batch‑to‑batch consistency. Key differentiators include:
- Technical expertise: Our chemists have decades of experience in peptide acylation and purification challenges, ensuring that lipophilic peptides like semaglutide meet stringent purity criteria without residual solvents or scavengers.
- Competitive pricing: Whether you need a single 5 mg vial for pilot experiments or 500 g for institutional core facilities, we provide transparent, volume‑based pricing that supports budget‑conscious research.
- Custom synthesis capabilities: Beyond the standard sequence, we can produce analog peptides with modifications such as N‑terminal acetylation, C‑terminal amidation, biotinylation, fluorescent labels (FITC, Cy5), or stable‑isotope labeling (¹³C, ¹⁵N) for quantitative mass spectrometry. We also offer peptide‑fatty acid conjugates with different chain lengths or spacer chemistry.
- Analytical support: Comprehensive data packages including raw chromatograms, spectra, and CoAs are provided electronically pre‑shipment. Additional characterizations—circular dichroism, dynamic light scattering, or aggregation propensity assays—can be arranged for an extra fee.
Our customer base spans university laboratories, pharmaceutical R&D groups, and authorized distributors across North America, Europe, and Asia. We maintain a dedicated technical support team that responds to inquiries about solubility, handling, and stability within 24 hours.
Frequently Asked Questions (FAQs)
Q: What is the purity of your semaglutide?
A: Each batch is tested by RP‑HPLC at 214 nm, and the typical purity is ≥98%. The exact figure appears on the lot‑specific Certificate of Analysis. Impurity profiles are monitored, and any single impurity above 0.5% is reported.
Q: How should the peptide be handled upon receipt?
A: Keep the unreconstituted vial at −20°C until use. To dissolve, add an appropriate volume of sterile water or buffer (e.g., PBS, pH 7.4) to achieve the desired concentration. Allow the powder to hydrate completely—gentle swirling or brief sonication may help. Once in solution, aliquot into single‑use portions and store immediately at −80°C. Avoid repeated freeze‑thaw cycles, as they can promote aggregation and loss of activity.
Q: Is this product for human use?
A: No. This semaglutide raw material is manufactured strictly for réservé à un usage de recherche en laboratoire. It has not been sterilized, formulated, or tested for safety or performance in humans or animals. Any use outside of controlled bench‑top or preclinical research settings is not permitted. Purchasers assume full responsibility for ensuring that their protocols comply with all applicable laws and institutional guidelines.
Research use note: All products described herein are intended solely for use in in vitro experiments or preclinical research by qualified professionals. They are not to be employed for any diagnostic procedure, medical application, or administration to humans or veterinary subjects.
Réservé à la recherche. Ne pas utiliser chez l'homme ni chez les animaux.
